1Michiel DF, Oppenheim JJ. Cytokines as positive and negative regulators of tumor promotion and progression. Semin Cancer Biol, 1992, 3(1):3 被引量：1
2Argiles JM, Lopez-Soriano FJ, Evans RD, et al. Interleukin-1 and lipid metabolism in the rat. Biochem J, 1989,259(3) :673 被引量：1
3Kwong LK, Ridinger DN, Bandhauer M, et al, Acute dyslipoproteinemia induced by interleukin-2 : lecithin : cholesteryl acyhransferase, lipoprotein lipase, and hepatic lipase deficiencies. J Clin Endocrinol Metab, 1997, 82(5):15 被引量：1
4Jiang JT, Nilsson-Ehle P, Xu N, Influence of liver cancer on lipid and lipoprotein metabolism. Lipids Health Dis,2006, 5(3) :4 被引量：1
5Eichholzer M, Stahelin HB, Gutzwiller F, et al. Association of low plasma cholesterol with mortality for cancer at various sites in men: 17-y follow-up of the prospective Basel study.Am J Clin Nutr, 2000, 71(2) :569 被引量：1
6Panagiotakos DB, Pitsavos C, Polychronopoulos E, et al. Total cholesterol and body mass index in relation to 40-year cance rmortality (the Corfu cohort of the seven countries study).Cancer Epidemiol Biomarkers Prey,2005, 14 (7) : 1 797 被引量：1
7Eggens I, Ekstrom T J, Aberg F. Studies on the biosynthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas. J Exp Pathol (Oxford),1990, 71(2) :219 被引量：1
8Tomiki Y, Suda S, Tanaka M, et al. Reduced low-densitylipoprotein cholesterol causing low serum cholesterol levels in gastrointestinal cancer: a case control study. J Exp Clin Cancer Res, 2004, 23(2) :233 被引量：1
9Ooi K, Shiraki K, Sakurai Y, et al. Clinical significance of abnormal lipoprotein patterns in liver diseases, Int J Mol Med, 2005,15(4) :655 被引量：1
10Fujii S, Koga S, Shono T, et al. Serum apoprotein A-Ⅰ and A- Ⅱ levels in liver diseases and cholestasis. Clin Chim Acta, 1981, 115(3):321 被引量：1
